US502504A
(en)
*
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2288422A
(en)
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
DE920245C
(de)
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
*
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
NL185660B
(nl)
|
1953-03-06 |
|
Great Lakes Chemical Corp |
Werkwijze voor het bereiden van alkali- of aardalkalimetaalbromiden.
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
NL193403A
(xx)
*
|
1953-12-22 |
1924-02-17 |
|
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(xx)
|
1959-08-14 |
|
|
|
NL277511A
(xx)
|
1961-04-21 |
|
|
|
CH479557A
(de)
|
1961-09-11 |
1969-10-15 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer mehrbasischer Verbindungen
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
*
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(xx)
|
1965-06-09 |
1968-02-21 |
|
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
SE370866B
(xx)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
*
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3646059A
(en)
*
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3668222A
(en)
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
JPS5031039A
(xx)
|
1973-07-27 |
1975-03-27 |
|
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
US4111680A
(en)
|
1973-07-27 |
1978-09-05 |
Shionogi & Co., Ltd. |
Herbicidal compositions containing 3-isoxazolylurea derivatives
|
CH575208A5
(xx)
|
1973-07-30 |
1976-05-14 |
Ciba Geigy Ag |
|
US4001256A
(en)
*
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
*
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
US4071524A
(en)
*
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
*
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
*
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
GB2080808B
(en)
|
1980-01-25 |
1984-01-04 |
Reanal Finomvegyszergyar |
Process for the preparation of n-aryl-n-(mono- or disubstituted)-urea derivatives
|
DE3174885D1
(en)
|
1981-02-03 |
1986-07-31 |
Ici Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
*
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
IL69621A0
(en)
|
1982-09-02 |
1983-12-30 |
Duphar Int Res |
Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
|
CA1254212A
(en)
*
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
*
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
JPS6120039A
(ja)
|
1984-07-06 |
1986-01-28 |
Konishiroku Photo Ind Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
*
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
EP0255297B1
(en)
*
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation, and their pharmaceutical use
|
NZ221964A
(en)
*
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
US4983605A
(en)
*
|
1986-10-23 |
1991-01-08 |
Ishihara Sangyo Kaisha Ltd. |
Pharmaceutical composition
|
DE3636190A1
(de)
*
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
DD253997A1
(de)
|
1986-11-26 |
1988-02-10 |
Karl Marx Uni Buero Fuer Neuer |
Verfahren zur herstellung von substituierten 2-arylureidophenolen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
ATE121742T1
(de)
|
1987-10-16 |
1995-05-15 |
Ciba Geigy Ag |
Schädlingsbekämpfungsmittel.
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
JPH0223337A
(ja)
|
1988-07-12 |
1990-01-25 |
Konica Corp |
新規なカプラーを含有するハロゲン化銀写真感光材料
|
WO1990002112A1
(en)
|
1988-08-23 |
1990-03-08 |
The Nutrasweet Company |
Substituted aryl ureas as high potency sweeteners
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
*
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
US5177110A
(en)
*
|
1989-10-27 |
1993-01-05 |
Ciba-Geigy Corporation |
Injectable parasiticidal composition
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
CA2051705A1
(en)
*
|
1990-06-19 |
1991-12-20 |
Kiyoaki Katano |
Pyridine derivatives having angiotensin ii antagonism
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
ATE157355T1
(de)
|
1991-01-21 |
1997-09-15 |
Shionogi & Co |
3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
|
JP2671693B2
(ja)
|
1991-03-04 |
1997-10-29 |
松下電器産業株式会社 |
バイオセンサおよびその製造法
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
FI921595A
(fi)
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamycinkarbamater
|
US5721237A
(en)
*
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
US5185358A
(en)
*
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
FR2683818B1
(fr)
|
1991-11-14 |
1993-12-31 |
Adir Cie |
Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US5508288A
(en)
*
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
US6001860A
(en)
|
1992-05-28 |
1999-12-14 |
Pfizer Inc. |
N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
ZA935111B
(en)
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
ZA935112B
(en)
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
KR950702994A
(ko)
|
1992-08-12 |
1995-08-23 |
로렌스 티. 웰츠 |
탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
DE4227989A1
(de)
|
1992-08-21 |
1994-06-09 |
Schering Ag |
Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
*
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(xx)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
AU6633694A
(en)
|
1993-04-09 |
1994-11-08 |
Board Of Regents Of The University Of Nebraska, The |
Novel methods and compositions for the treatment of (ras)-activated cancer with heterotypic anti-(raf) antisense oligonucleotides
|
GB9308802D0
(en)
|
1993-04-28 |
1993-06-09 |
Smithkline Beecham Plc |
Treatment
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US6514745B1
(en)
*
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
NZ264063A
(en)
*
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US6361773B1
(en)
*
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
ATE186551T1
(de)
*
|
1993-09-17 |
1999-11-15 |
Smithkline Beecham Corp |
Medikamente bindendes protein
|
US5869043A
(en)
*
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
JPH09505055A
(ja)
|
1993-11-08 |
1997-05-20 |
スミスクライン・ビーチャム・コーポレイション |
サイトカイン媒介疾患治療用オキサゾール
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
CA2175215C
(en)
|
1993-11-19 |
2008-06-03 |
Yat Sun Or |
Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
|
DK0734389T3
(da)
|
1993-12-17 |
2000-08-21 |
Novartis Ag |
Rapamycinderivater, som er anvendelige som immunosuppressive midler
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
*
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
WO1995033458A1
(en)
*
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5447957A
(en)
*
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
*
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
JPH10510512A
(ja)
|
1994-10-04 |
1998-10-13 |
藤沢薬品工業株式会社 |
尿素誘導体とacat阻害剤としての用途
|
ATE220661T1
(de)
|
1994-10-19 |
2002-08-15 |
Novartis Erfind Verwalt Gmbh |
Antivirale ether von aspartat-protease-substrat- isosteren
|
CA2161376C
(en)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
JP3591938B2
(ja)
|
1994-10-27 |
2004-11-24 |
キヤノン株式会社 |
インクジェット用記録媒体及びこれを用いた画像形成方法
|
EP0788564B1
(en)
|
1994-10-28 |
2001-05-16 |
Novozymes A/S |
A process for chemical finishing of insoluble polymer fibres
|
TW313568B
(xx)
*
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
JPH11503110A
(ja)
|
1995-02-17 |
1999-03-23 |
スミスクライン・ビーチャム・コーポレイション |
Il−8受容体拮抗剤
|
US5780483A
(en)
*
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
DE19512639A1
(de)
*
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
IL122212A
(en)
|
1995-06-09 |
2001-08-26 |
Novartis Ag |
Rapamycin derivatives, pharmaceutical compositions comprising them and their preparation
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
ZA967840B
(en)
*
|
1995-09-18 |
1997-04-07 |
Sankyo Co |
New urea derivatives having a cat inhibitory activity their preparation and their therapeutic and prophylactic use
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
EP0860433B1
(en)
|
1995-11-07 |
2002-07-03 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
DE69627709T2
(de)
*
|
1995-12-28 |
2004-02-26 |
Kureha Kagaku Kogyo K.K. |
N-(unsubstituierte oder substituierte)-4-substituierte-6-(unsubstituierte oder substituierte)phenoxy-2-pyridincarboxamide oder -thiocarboxamide, verfahren zu deren herstellung sowie herbizide
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
*
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
US6262113B1
(en)
*
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US5891895A
(en)
*
|
1996-04-15 |
1999-04-06 |
Takeda Chemical Industries, Ltd. |
Hydroxypyridine derivatives their production and use
|
HUP0004421A3
(en)
|
1996-04-23 |
2002-10-28 |
Vertex Pharmaceuticals Inc Cam |
Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
*
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
NZ332789A
(en)
|
1996-05-24 |
2000-05-26 |
Neurosearch As |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
JP2000514789A
(ja)
*
|
1996-06-27 |
2000-11-07 |
スミスクライン・ビーチャム・コーポレイション |
Il―8受容体拮抗薬
|
JP2000514049A
(ja)
*
|
1996-06-27 |
2000-10-24 |
スミスクライン・ビーチャム・コーポレイション |
Il―8受容体拮抗薬
|
JP2000513360A
(ja)
*
|
1996-06-27 |
2000-10-10 |
スミスクライン・ビーチャム・コーポレイション |
Il―8レセプターアンタゴニスト
|
WO1997049399A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
WO1998000402A1
(en)
|
1996-06-29 |
1998-01-08 |
Samjin Pharmaceutical Co., Ltd. |
Piperazine derivatives and process for the preparation thereof
|
US6150415A
(en)
*
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
US5808080A
(en)
|
1996-09-05 |
1998-09-15 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
US6019793A
(en)
|
1996-10-21 |
2000-02-01 |
Synthes |
Surgical prosthetic device
|
US5965573A
(en)
*
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
AU4988997A
(en)
|
1996-10-23 |
1998-05-15 |
Osteoscreen, Inc. |
Compositions and methods for treating bone deficit conditions
|
DE69739734D1
(de)
*
|
1996-11-15 |
2010-02-25 |
Cytokine Pharmasciences Inc |
Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
TR199901710T2
(xx)
|
1997-01-23 |
1999-09-21 |
Smithkline Beecham Corporation |
IL-8 resept�r antagonistleri.
|
US5929250A
(en)
*
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0971908B1
(en)
|
1997-02-12 |
2004-06-30 |
SmithKline Beecham Corporation |
Il-8 receptor antagonists
|
US20020111495A1
(en)
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
ID22781A
(id)
|
1997-04-04 |
1999-12-09 |
Pfizer Prod Inc |
Turunan-turunan nikotinamida
|
AU6783698A
(en)
*
|
1997-04-10 |
1998-10-30 |
Pharmacia & Upjohn Company |
Polyaromatic antiviral compositions
|
WO1998049150A1
(en)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
*
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
JP2002502380A
(ja)
|
1997-05-22 |
2002-01-22 |
ジー.ディー.サール アンド カンパニー |
p38キナーゼ阻害剤としてのピラゾール誘導体
|
KR20010012808A
(ko)
|
1997-05-22 |
2001-02-26 |
윌리암스 로저 에이 |
p38 키나아제로서 4-아릴-3(5)-헤테로아릴 치환 피라졸
|
AU7585598A
(en)
*
|
1997-05-23 |
1998-12-11 |
Bayer Corporation |
Raf kinase inhibitors
|
ES2151467T3
(es)
*
|
1997-05-23 |
2005-03-01 |
Bayer Corporation |
Arilureas para el tratamiento de enfermedades inflamatorias o inmunomoduladoras.
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
US5985592A
(en)
*
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
CA2294057A1
(en)
|
1997-06-13 |
1998-12-17 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
WO1999000370A1
(fr)
|
1997-06-27 |
1999-01-07 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Acide 6-phenoxypicolinique, derives d'alkylidenehydrazide, leur procede de production, et herbicide
|
US6093742A
(en)
*
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
US6525065B1
(en)
*
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
*
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
WO1999020617A1
(en)
|
1997-10-21 |
1999-04-29 |
Active Biotech Ab |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
AU748041B2
(en)
|
1997-10-31 |
2002-05-30 |
Aventis Pharma Limited |
Substituted anilides
|
US6080763A
(en)
|
1997-11-03 |
2000-06-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
|
US6022884A
(en)
*
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
KR20010031912A
(ko)
|
1997-11-10 |
2001-04-16 |
스티븐 비. 데이비스 |
벤조티아졸 단백질 티로신 키나제 억제제
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
AU1407899A
(en)
|
1997-12-01 |
1999-06-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
WO1999032111A1
(en)
*
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
CA2315717C
(en)
|
1997-12-22 |
2011-02-01 |
Bayer Corporation |
Inhibition of raf kinase using substituted heterocyclic ureas
|
TR200002617T2
(tr)
|
1997-12-22 |
2000-11-21 |
Bayer Corporation |
Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi
|
CA2315715C
(en)
*
|
1997-12-22 |
2010-06-22 |
Bayer Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
IL136768A0
(en)
|
1997-12-22 |
2001-06-14 |
Bayer Ag |
INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
DE1049664T1
(de)
*
|
1997-12-22 |
2001-05-03 |
Bayer Ag |
Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
AU1712899A
(en)
|
1997-12-23 |
1999-07-12 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
WO1999033458A1
(fr)
|
1997-12-25 |
1999-07-08 |
Daiichi Pharmaceutical Co., Ltd. |
Composition medicinale pour administration percutanee
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
US6221913B1
(en)
*
|
1998-01-21 |
2001-04-24 |
Zymogenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
DE69907155T2
(de)
*
|
1998-02-18 |
2004-02-05 |
Theryte Ltd. |
Krebsbehandlung
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
*
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
*
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
WO2000017175A1
(en)
|
1998-09-18 |
2000-03-30 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
HUP0104302A3
(en)
|
1998-11-06 |
2002-11-28 |
Abbott Gmbh & Co Kg |
Inhibition of the formation of vascular hyperpermeability
|
AU2156600A
(en)
|
1998-11-25 |
2000-06-13 |
Cold Spring Harbor Laboratory |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
US6331541B1
(en)
*
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
EP1140087A4
(en)
|
1998-12-18 |
2002-04-03 |
Du Pont Pharm Co |
N-UREIDOALKYL-PIPERIDINES FOR USE AS MODULATORS OF THE ACTIVITY OF CHIMIOKIN RECEPTORS
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
DE69926542T2
(de)
*
|
1998-12-25 |
2006-04-27 |
Teikoku Hormone Mfg. Co., Ltd. |
Aminopyrazolderivate
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
IL144144A0
(en)
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
TWI284642B
(en)
*
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
PL204856B1
(pl)
|
1999-01-22 |
2010-02-26 |
Kirin Pharma Kk |
Pochodne chinoliny lub chinazoliny, jej zastosowanie i kompozycja farmaceutyczna
|
US6699879B1
(en)
|
1999-02-12 |
2004-03-02 |
Smithkline Beecham P.L.C. |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
MXPA01009077A
(es)
|
1999-03-12 |
2002-03-27 |
Boehringer Ingelheim Pharma |
Composiciones heterociclicos aromaticos como agentes anti-inflamatorios.
|
DE60014603T2
(de)
*
|
1999-03-12 |
2006-02-16 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
|
EP1964561A1
(en)
|
1999-03-19 |
2008-09-03 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6414011B1
(en)
|
1999-03-26 |
2002-07-02 |
Euro-Celtique S.A. |
Aryl substituted pyrazoles, and pyrroles, and the use thereof
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
ATE263162T1
(de)
|
1999-05-05 |
2004-04-15 |
Aventis Pharma Ltd |
Harnstoffderivate und ihr gebrauch als zell adhesion modulatoren
|
SK16522001A3
(sk)
|
1999-05-14 |
2002-10-08 |
Imclone Systems Incorporated |
Liečivo na inhibíciu rastu refraktérnych nádorov
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
EP1557168B1
(en)
|
1999-07-26 |
2011-11-16 |
Msd K.K. |
Biarylurea Derivatives
|
ATE321751T1
(de)
|
1999-07-28 |
2006-04-15 |
Kirin Brewery |
Harnstoffderivate als ccr-3 rezeptor-inhibitoren
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
MXPA02003742A
(es)
|
1999-10-15 |
2003-10-14 |
Kampen Group Inc Van |
Tratamiento de tumores dermicos, verrugas e infecciones virales usando p. acnes muerto por calor.
|
US6794393B1
(en)
|
1999-10-19 |
2004-09-21 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
CA2389360C
(en)
|
1999-11-16 |
2008-06-03 |
Steffen Breitfelder |
Urea derivatives as anti-inflammatory agents
|
EP1242382B1
(en)
|
1999-12-29 |
2007-02-07 |
Wyeth |
Tricyclic protein kinase inhibitors
|
US6525046B1
(en)
*
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
BR0108085A
(pt)
|
2000-02-07 |
2003-03-18 |
Abbott Gmbh & Co Kg |
Derivados de 2-benzotiazolil uréia e seu uso como inibidores da cinase protéica
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
US6658473B1
(en)
|
2000-02-25 |
2003-12-02 |
Sun Microsystems, Inc. |
Method and apparatus for distributing load in a computer environment
|
AU4194601A
(en)
|
2000-03-02 |
2001-09-12 |
Ludwig Institute For Cancer Research |
Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor
|
JP2003525897A
(ja)
|
2000-03-06 |
2003-09-02 |
アストラゼネカ アクチボラグ |
治 療
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
WO2002007008A1
(en)
|
2000-04-28 |
2002-01-24 |
Ubink Cornelis Hubertus Johann |
Network procurement system
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
AU2001276934A1
(en)
|
2000-07-18 |
2002-02-05 |
Joslin Diabetes Center Inc. |
Methods of modulating fibrosis
|
WO2002007772A2
(en)
|
2000-07-24 |
2002-01-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Improved oral dosage formulations
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
MXPA03000937A
(es)
|
2000-08-04 |
2004-08-02 |
Univ Loma Linda Med |
Proteina reguladora del hierro (irp-2) como un diagnostico para enfermedades neurodegenerativas.
|
MXPA03001256A
(es)
|
2000-08-11 |
2004-12-06 |
Vertex Pharma |
Inhibidores de p38.
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
KR20040066185A
(ko)
|
2000-08-17 |
2004-07-23 |
샤단호칭키타사토겐큐쇼 |
신규 슈도에리쓰로마이신 유도체
|
EP1313710A1
(en)
|
2000-08-31 |
2003-05-28 |
Pfizer Products Inc. |
Pyrazole derivatives and their use as protein kinase inhibitors
|
WO2002025286A2
(en)
|
2000-09-20 |
2002-03-28 |
The President And Fellows Of Harvard College |
Methods for the diagnosis of neoplastic disorders using angiogenin
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
AU2001295986B2
(en)
|
2000-10-20 |
2006-08-17 |
Eisai R&D Management Co., Ltd |
Nitrogenous aromatic ring compounds
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
AU2002223500A1
(en)
|
2000-11-17 |
2002-05-27 |
Novo-Nordisk A/S |
Glucagon antagonists/inverse agonists
|
AU2002217870A1
(en)
|
2000-11-27 |
2002-06-03 |
Eric A. Brill |
System, method, and program for sorting objects
|
DE60123461T2
(de)
|
2000-11-28 |
2007-02-15 |
Pfizer Products Inc., Groton |
Salze eines 4-isothiazolcarboxamids und ihre verwendung als anti-hyperproliferationsmittel
|
US7238813B2
(en)
|
2000-11-29 |
2007-07-03 |
Smithkline Beecham Corporation |
Chemical compounds
|
JPWO2002045733A1
(ja)
*
|
2000-12-08 |
2004-06-10 |
協和醗酵工業株式会社 |
鎮痒または抗掻痒活性を有する経口剤
|
CA2432429A1
(en)
|
2000-12-21 |
2002-06-27 |
Glaxo Group Limited |
Macrolide antibiotics
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
MXPA03006666A
(es)
|
2001-01-25 |
2004-05-31 |
Guilford Pharm Inc |
Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
DK3143995T3
(en)
|
2001-02-19 |
2019-01-28 |
Novartis Pharma Ag |
Rapamycin derivative for the treatment of lung cancer
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US6525091B2
(en)
*
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
JP2004528311A
(ja)
|
2001-03-07 |
2004-09-16 |
テリック,インコーポレイテッド |
Fas媒介アポトーシスの刺激剤としての置換ジアリールウレア
|
PE20020958A1
(es)
|
2001-03-23 |
2002-11-14 |
Bayer Corp |
Inhibidores de la rho-quinasa
|
IL157946A0
(en)
|
2001-04-02 |
2004-03-28 |
Genentech Inc |
Combination therapy
|
MXPA03009361A
(es)
|
2001-04-13 |
2004-01-29 |
Boehringer Ingelheim Pharma |
Compuestos de urea utilies como agentes anti-inflamatorios.
|
EP1381592A1
(en)
|
2001-04-13 |
2004-01-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused compounds
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
CA2443950C
(en)
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
WO2002088090A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitors
|
WO2002092576A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
WO2003004523A1
(en)
|
2001-07-02 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human citron rho/rac-interacting kinase
|
CA2453147A1
(en)
|
2001-07-11 |
2003-01-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
MEP36208A
(en)
|
2001-12-03 |
2011-02-10 |
Bayer Corp |
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
|
JP2005526008A
(ja)
|
2001-12-04 |
2005-09-02 |
オニックス ファーマシューティカルズ,インコーポレイティド |
癌を処置するためのraf−mek−erk経路インヒビター
|
BRPI0214840B8
(pt)
|
2001-12-21 |
2021-05-25 |
The Wellcome Trust |
métodos para a detecção de mutações oncogênicas humanas, métodos automatizados para detectar uma mutação e método e ensaio para identificar um ou mais compostos tendo atividade anti-proliferativa
|
AU2002356323A1
(en)
|
2001-12-24 |
2003-07-30 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
WO2003059373A2
(en)
|
2002-01-16 |
2003-07-24 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
US20050026868A1
(en)
|
2003-07-11 |
2005-02-03 |
Metcalf Chester A. |
Phosphorus-containing macrocycles
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
PT1580188E
(pt)
|
2002-02-11 |
2012-01-25 |
Bayer Healthcare Llc |
Aril-ureias como inibidores de cinases
|
AU2003210969A1
(en)
*
|
2002-02-11 |
2003-09-04 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenesis inhibiting activity
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
CA2475703C
(en)
|
2002-02-11 |
2016-12-20 |
Bayer Pharmaceuticals Corporation |
Aryl ureas with angiogenesis inhibiting activity
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
MXPA04009541A
(es)
|
2002-03-29 |
2005-01-25 |
Chiron Corp |
Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
|
DE10221524A1
(de)
|
2002-05-14 |
2003-12-04 |
Kmb Produktions Ag Felben |
Verfahren und Vorrichtung zum Herstellen von Verzehrgütern
|
AU2003233576A1
(en)
|
2002-05-17 |
2003-12-02 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
AU2003246927A1
(en)
|
2002-07-03 |
2004-01-23 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
DE60322544D1
(de)
|
2002-08-27 |
2008-09-11 |
Merck Patent Gmbh |
Glycinamid-derivate als raf-kinase-hemmer
|
CN100497302C
(zh)
|
2002-09-05 |
2009-06-10 |
神经研究公司 |
二芳基脲衍生物和它们作为氯通道阻滞剂的用途
|
BR0315580A
(pt)
|
2002-10-24 |
2005-08-30 |
Merck Patent Gmbh |
Derivados de metileno uréia
|
WO2004043374A2
(en)
|
2002-11-06 |
2004-05-27 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for treating cancer using proteasome inhibitors
|
CN1714085A
(zh)
|
2002-11-15 |
2005-12-28 |
诺瓦提斯公司 |
药物递送系统
|
PT1578742E
(pt)
|
2002-12-06 |
2013-01-24 |
Nycomed Gmbh |
Processo para preparar compostos activos opticamente puros
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
EP1608639A2
(en)
|
2003-02-28 |
2005-12-28 |
Bayer Pharmaceuticals Corporation |
Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
|
WO2004078128A2
(en)
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
ATE489379T1
(de)
|
2003-02-28 |
2010-12-15 |
Bayer Healthcare Llc |
2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
|
US7557129B2
(en)
*
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
US20060189665A1
(en)
|
2003-03-24 |
2006-08-24 |
Merck Patent Gmbh |
Oxamide derivatives useful as raf-kinase inhibitors
|
WO2004084889A1
(en)
|
2003-03-28 |
2004-10-07 |
Pfizer Inc. |
Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
US7537346B2
(en)
|
2005-03-03 |
2009-05-26 |
Superimaging, Inc. |
Display having integrated light emitting material
|
US20070020704A1
(en)
*
|
2003-05-20 |
2007-01-25 |
Scott Wilhelm |
Diaryl ureas with kinase inhibiting activity
|
BRPI0410913A
(pt)
|
2003-06-05 |
2006-06-27 |
Warner Lambert Co |
benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
WO2005005389A2
(en)
|
2003-07-07 |
2005-01-20 |
Merck Patent Gmbh |
Malonamide derivatives
|
ES2316995T3
(es)
|
2003-07-08 |
2009-04-16 |
Novartis Ag |
Uso de rapamicina y derivados de rapamicida para el tratamiento de la perdida osea.
|
JP5001650B2
(ja)
|
2003-07-11 |
2012-08-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンズイミダゾールカルボキサミド
|
EP1653951B1
(en)
|
2003-07-11 |
2011-12-28 |
Merck Patent GmbH |
Benzimidazole derivatives as raf kinase inhibitors
|
US20060234931A1
(en)
|
2003-07-17 |
2006-10-19 |
Biggs William H Iii |
Treatment of diseases with kinase inhibitors
|
NZ580384A
(en)
|
2003-07-23 |
2011-03-31 |
Bayer Pharmaceuticals Corp |
4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
|
TW200523262A
(en)
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
WO2005016126A2
(en)
*
|
2003-08-15 |
2005-02-24 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Multifactorial assay for cancer detection
|
KR20060097000A
(ko)
|
2003-09-23 |
2006-09-13 |
노파르티스 아게 |
화학요법제와 vegf 수용체 저해제의 배합물
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
EP1678123A1
(en)
*
|
2003-10-15 |
2006-07-12 |
Bayer HealthCare AG |
Tetrahydro-naphthalene and urea derivatives
|
CN1882345A
(zh)
|
2003-10-16 |
2006-12-20 |
希龙公司 |
作为raf激酶抑制剂以治疗癌症的2,6-二取代的喹唑啉、喹喔啉、喹啉和异喹啉
|
ES2327418T3
(es)
|
2003-10-16 |
2009-10-29 |
Novartis Vaccines And Diagnostics, Inc. |
Benzazoles sustituidos y uso de los mismos como inhibidores de la quinasa raf.
|
DE10349587A1
(de)
*
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
US20050171171A1
(en)
|
2003-11-13 |
2005-08-04 |
Ambit Biosciences Corporation |
Amide derivatives as FLT-3 modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
EP1711196A4
(en)
|
2003-12-05 |
2011-09-14 |
Bristol Myers Squibb Co |
INHIBITORS OF TYPE-2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
|
KR20060123463A
(ko)
|
2003-12-09 |
2006-12-01 |
더 거번먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 레프리젠티드 바이 더 세크러터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 |
면역 반응을 억제하거나 증식성 장애를 치료하는 방법들
|
EP1692110A1
(en)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Diacylhydrazine derivatives
|
WO2005059179A1
(en)
|
2003-12-12 |
2005-06-30 |
Bayer Pharmaceutical Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
US20070161677A1
(en)
|
2004-01-30 |
2007-07-12 |
Merck Patent Gmbh |
Bisarylurea derivatives
|
AU2005223649A1
(en)
|
2004-03-19 |
2005-09-29 |
The Penn State Research Foundation |
Combinatorial methods and compositions for treatment of melanoma
|
EP1751139B1
(en)
|
2004-04-30 |
2011-07-27 |
Bayer HealthCare LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
CA2578442A1
(en)
|
2004-08-27 |
2006-03-09 |
Bayer Pharmaceuticals Corporation |
Pharmaceutical compositions comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methyl amide for the treatment of cancer
|
MY191349A
(en)
*
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
EP1797096B1
(en)
|
2004-09-06 |
2011-07-27 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolopyrimidines as inhibitors of protein kinase b (akt)
|
JP5215666B2
(ja)
|
2004-09-29 |
2013-06-19 |
バイエル・ファルマ・アクチェンゲゼルシャフト |
Bay43−9006トシレートの熱力学的に安定な形態
|
BRPI0515944B1
(pt)
|
2004-09-29 |
2021-11-09 |
Bayer Healthcare Llc |
Processo para a preparação de 4-{4-[({[4-cloro-3-(trifluorometil)fe-nil]amino}carbonil) amino]fenóxi}nmetilpiridina-2-carboxamida
|
WO2006076592A1
(en)
|
2005-01-14 |
2006-07-20 |
Cgi Pharmaceuticals, Inc. |
1,3 substituted diaryl ureas as modulators of kinase activity
|
CA2601955C
(en)
|
2005-03-07 |
2012-07-10 |
Bayer Healthcare Ag |
Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
KR20080012902A
(ko)
|
2005-05-27 |
2008-02-12 |
바이엘 헬스케어 아게 |
질병을 치료하기 위한 디아릴 우레아를 포함하는 병용요법
|
JP2008542214A
(ja)
|
2005-05-27 |
2008-11-27 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
疾患を処置するためのジアリールウレア化合物およびpi3、aktキナーゼまたはmtor阻害剤(ラパマイシン)を含む組合せ治療
|
EP1937837A2
(en)
|
2005-07-29 |
2008-07-02 |
Siemens Healthcare Diagnostics Inc. |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
US20070037224A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Hamer Peter J |
Quantitative assays for PDGFR-beta in body fluids
|
US8188138B2
(en)
|
2005-09-21 |
2012-05-29 |
4Sc Ag |
Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
|
WO2007039404A1
(en)
|
2005-09-21 |
2007-04-12 |
Nycomed Gmbh |
Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles
|
US20090221010A1
(en)
|
2005-10-21 |
2009-09-03 |
Elting James J |
Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
EP2289515A3
(en)
*
|
2005-10-31 |
2012-04-11 |
Bayer HealthCare LLC |
Combinations comprising a diaryl urea and an interferon
|
WO2007053573A2
(en)
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
WO2007056011A2
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
WO2007056012A2
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP1948170A1
(en)
*
|
2005-11-10 |
2008-07-30 |
Bayer HealthCare AG |
Diaryl urea for treating pulmonary hypertension
|
PT1948176E
(pt)
|
2005-11-10 |
2011-03-07 |
Bayer Schering Pharma Ag |
Diaril ureias para tratar a hipertensão pulmonar
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
EP1957069A2
(en)
|
2005-11-14 |
2008-08-20 |
Bayer Healthcare, LLC |
Treatment of cancers with acquired resistance to kit inhibitors
|
CN101454668A
(zh)
|
2005-11-14 |
2009-06-10 |
拜耳医药保健有限责任公司 |
癌症预测与预后以及监测癌症治疗的方法
|
MX2008006979A
(es)
|
2005-12-01 |
2009-01-14 |
Bayer Healthcare Llc |
Compuestos de urea utiles en el tratamiento contra el cancer.
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
US20090197922A1
(en)
|
2006-01-24 |
2009-08-06 |
The University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
NZ571356A
(en)
|
2006-02-22 |
2010-08-27 |
4Sc Ag |
Indolopyridines as EG5 kinesin modulators
|
CA2643488C
(en)
|
2006-02-22 |
2014-08-05 |
4Sc Ag |
Indolopyridines as eg5 kinesin modulators
|
US7908091B2
(en)
|
2006-03-17 |
2011-03-15 |
Prometheus Laboratories Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
CA2648106A1
(en)
|
2006-03-31 |
2007-11-01 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP2338488A1
(en)
|
2006-05-26 |
2011-06-29 |
Bayer HealthCare, LLC |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
MX2009004861A
(es)
|
2006-11-09 |
2009-05-21 |
Abbott Gmbh & Co Kg |
Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa.
|
EP2111401B1
(en)
|
2006-12-20 |
2011-02-16 |
Bayer HealthCare, LLC |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
|
JP2010514692A
(ja)
|
2006-12-20 |
2010-05-06 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌の治療に有用なヒドロキシメチルフェニルピラゾリル尿素化合物
|
CA2675980C
(en)
|
2007-01-19 |
2016-06-21 |
Bayer Healthcare Llc |
Use of dast for treatment of cancers with acquired resistance to kit inhibitors
|
CA2698795C
(en)
|
2007-09-10 |
2016-04-19 |
Cipla Limited |
Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
|
WO2009054004A2
(en)
|
2007-10-22 |
2009-04-30 |
Natco Pharma Limited |
Process for the preparation of sorafenib
|
US8722715B2
(en)
|
2008-11-07 |
2014-05-13 |
NovaBay Pharmaceuticals |
Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
|
GB0823587D0
(en)
|
2008-12-29 |
2009-01-28 |
South West Refrigeration |
Dairy heat reclamation system
|
JP5821626B2
(ja)
|
2011-12-27 |
2015-11-24 |
富士ゼロックス株式会社 |
画像形成装置及びプログラム
|